Guard Therapeutics International AB (publ) 5LH.F Stock
Guard Therapeutics International AB (publ) Price Chart
Guard Therapeutics International AB (publ) 5LH.F Financial and Trading Overview
Contents
- Guard Therapeutics International AB (publ) Price Chart
- Guard Therapeutics International AB (publ) 5LH.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Guard Therapeutics International AB (publ)
- Q&A For Guard Therapeutics International AB (publ) Stock
| Guard Therapeutics International AB (publ) stock price | 0.05 EUR |
| Previous Close | 0.0062 EUR |
| Open | 0.0038 EUR |
| Bid | 0.0054 EUR x N/A |
| Ask | 0.02 EUR x N/A |
| Day's Range | 0.0038 - 0.0038 EUR |
| 52 Week Range | 0.0002 - 0.1 EUR |
| Volume | 50 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 3.43M EUR |
| Beta (5Y Monthly) | 1.276245 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
5LH.F Valuation Measures
| Enterprise Value | 3.12M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Guard Therapeutics International AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.276245 |
| 52-Week Change | -91.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 EUR |
| 52 Week Low | 0.0002 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.06 EUR |
5LH.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 503.08M |
| Float | 417.36M |
| Short Ratio | N/A |
| % Held by Insiders | 26.80% |
| % Held by Institutions | 35.55% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -49.64% |
| Return on Equity (ttm) | -90.75% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.945 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Guard Therapeutics International AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Nybrogatan 34, 2 tr |
| ZIP | 114 39 |
| Phone | 46 86 70 65 51 |
| Website | https://guardtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
Q&A For Guard Therapeutics International AB (publ) Stock
What is a current 5LH.F stock price?
Guard Therapeutics International AB (publ) 5LH.F stock price today per share is 0.05 EUR.
How to purchase Guard Therapeutics International AB (publ) stock?
You can buy 5LH.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Guard Therapeutics International AB (publ)?
The stock symbol or ticker of Guard Therapeutics International AB (publ) is 5LH.F.
Which industry does the Guard Therapeutics International AB (publ) company belong to?
The Guard Therapeutics International AB (publ) industry is Biotechnology.
How many shares does Guard Therapeutics International AB (publ) have in circulation?
The max supply of Guard Therapeutics International AB (publ) shares is 11.32M.
What is Guard Therapeutics International AB (publ) Price to Earnings Ratio (PE Ratio)?
Guard Therapeutics International AB (publ) PE Ratio is 0.00000000 now.
What was Guard Therapeutics International AB (publ) earnings per share over the trailing 12 months (TTM)?
Guard Therapeutics International AB (publ) EPS is 0 EUR over the trailing 12 months.
Which sector does the Guard Therapeutics International AB (publ) company belong to?
The Guard Therapeutics International AB (publ) sector is Healthcare.